Page 339 - Biodegradable Polyesters
P. 339

12.7  Conclusions and Outlook  317

                PLLA/PGA MFCs still hold some potential – additional drawing may increase
               the orientation of the PGA molecules further, perhaps enough to enhance their
               creep resistance. It may also be possible to modify PGA to increase its T ,thus
                                                                         g
               enhancing its creep resistance. It is indeed quite challenging to find a polymer
               with all of the listed characteristics but perhaps it is worthwhile searching beyond
               polymers which are normally considered biodegradable in the body, such as
               PLLA and PGA. For example, studies on explanted vascular graft devices made of
               poly(ethylene terephthalate) (PET) have shown that some degree of degradation
               occurred in vivo [48] and Rudakova et al. [49] report that PET is completely
               degraded in dogs and humans in 30 ± 7 years. This information invokes thinking
               more laterally about solutions – PET is just an example of a polymer which might
               be suitable if it is acceptable for it to remain in the vessel wall for many years
               after complete degradation of the stent matrix material. This is something which
               is yet another unknown: what is acceptable with regard to stent reinforcements?
               May they be biostable or very slow-degrading materials if the effect of their
               remaining in the vessel wall after the stent has degraded is neutral? Collaboration
               and formation of interdisciplinary teams are needed to answer these types of
               questions to guide effective research in this area in the future.
                Adding to this, there may be alternative polymer combinations – the matrix
               does not have to be PLLA. In fact, there may even be biodegradable polymer
               combinations for MFC in which, for example, PLLA is the reinforcing component
               surrounded by a ductile matrix. Furthermore, additional drawing steps could be
               added to maximize the orientation of the reinforcing polymer as well as decrease
               fibril diameters. A very interesting overlap of MFCs and particulate composites
               provides even more potential for improvement and scope for future work because,
               as mentioned before, nanoparticles could be used to modify the reinforcing poly-
               mer’s thermal properties to enhance creep resistance.


               12.7
               Conclusions and Outlook
               MFCs based on PLLA/PGA were successfully produced via cold-drawing of
               PLLA/PGA wire with excellent fibril formation in the case of PLLA/PGA MFC
               (70/30 by wt%). The MFC technique’s benefits are clear from the tensile test
               results – the PLLA/PGA MFCs are tougher, stiffer, and stronger than the simple
               PLLA/PGA blends from which they were derived. PLLA/PGA MFC (70/30 by
                                                                      ∘
               wt%) is 35% stiffer and 84% stronger than neat PLLA in tension at 37 C. Relax-
               ation tests at the same temperature indicate, however, that the creep resistance
               of PLLA/PGA MFCs is poorer than that of neat PLLA. DMTA results reveal that
               it is the onset of glass transition of PGA which is the underlying cause for the
               creep propensity of PLLA/PGA MFCs. For load-bearing implants, this highlights
               creep failure as a significant concern. Nevertheless, these fully biodegradable
               MFCs exhibit properties which may be favorable for applications beyond medical
               implants. Furthermore, there is still scope for development of the MFCs such
   334   335   336   337   338   339   340   341   342   343   344